In a report released today, Suraj Kalia from Northland Securities maintained a Buy rating on Strata Skin Sciences Inc (SSKN), with a price target of $7. The company’s shares closed last Monday at $1.80, close to its 52-week low of $1.69.
According to TipRanks.com, Kalia is a 4-star analyst with an average return of 7.3% and a 55.4% success rate. Kalia covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Varex Imaging Corporation, and Obalon Therapeutics Inc.
Strata Skin Sciences Inc has an analyst consensus of Moderate Buy, with a price target consensus of $6.
See today’s analyst top recommended stocks >>
Based on Strata Skin Sciences Inc’s latest earnings release for the quarter ending September 30, the company reported a quarterly GAAP net loss of $290K. In comparison, last year the company had a GAAP net loss of $1.36 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
STRATA Skin Sciences, Inc. is a medical technology company, which engages in the design, development, and commercializing of non-invasive tools to provide additional information to dermatologists during melanoma skin examinations.
